SI9815: JNJ26854165/Serdemetan

$237.00

In stock

Specifications

An oral, phase 1 hdm2 antagonist. Binds the RING domain of MDM2 and inhibits survival in cancer cells.

Info

Purity >99% (TLC), NMR (conforms)
Quantity 5 mg
Molecular Weight 328.41 Da
Physical State Lyophilized solid
Solubility DMSO (66mg/ml); Ethanol (<2mg/ml); Water (<1mg/ml)
CAS No. 881202-45-5
Storage 4°C, (-20°C Long term). The product can be shipped at room temperature.

Additional information

SKU

Reviews

There are no reviews yet.

Be the first to review “SI9815: JNJ26854165/Serdemetan”

Applications

  • Cell-based and in vitro studies of hdm2 function

Documents